Author Affiliations: Cedars-Sinai Medicine, Department of Medicine, Cedars-Sinai Health System, Los Angeles, California (Dr Green); Sections of General Internal Medicine (Dr Ross) and Cardiovascular Medicine (Dr Krumholz), Department of Medicine, and Section of Health Policy and Administration, Department of Epidemiology and Public Health, and Robert Wood Johnson Foundation Clinical Scholars Program (Dr Krumholz), Yale University School of Medicine, New Haven, Connecticut; Center for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven (Drs Ross and Krumholz); Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Los Angeles, and the Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada (Dr Jackevicius); and Division of Healthcare Policy and Research and Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota (Dr Shah).
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Alldredge BK, Kayser SR. Bending the Curve Toward Increased Use of Generic Drugs: Comment on “When Choosing Statin Therapy”. JAMA Intern Med. 2013;173(3):233–234. doi:10.1001/jamainternmed.2013.1777
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.